Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Insmed - 34 Year Stock Price History | INSM

Historical daily share price chart and data for Insmed since 1991 adjusted for splits and dividends. The latest closing stock price for Insmed as of June 18, 2025 is 99.46.
  • The all-time high Insmed stock closing price was 760.00 on December 30, 1991.
  • The Insmed 52-week high stock price is 102.00, which is 2.6% above the current share price.
  • The Insmed 52-week low stock price is 60.40, which is 39.3% below the current share price.
  • The average Insmed stock price for the last 52 weeks is 73.66.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Insmed Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 74.8657 69.9500 101.5900 64.8100 99.4600 44.06%
2024 53.5032 29.9400 79.0100 22.0000 69.0400 122.78%
2023 21.8417 19.1800 31.7400 16.2600 30.9900 55.11%
2022 21.8800 28.1300 28.2100 16.9800 19.9800 -26.65%
2021 30.5951 33.4200 44.3000 22.4600 27.2400 -18.17%
2020 28.2231 23.6600 40.5400 13.6300 33.2900 39.41%
2019 23.3077 13.9700 32.1900 13.9100 23.8800 82.01%
2018 22.6318 32.4600 32.9900 11.6000 13.1200 -57.92%
2017 20.2914 13.0800 31.7800 11.6100 31.1800 135.68%
2016 12.7351 17.2400 17.2400 9.0500 13.2300 -27.11%
2015 20.7534 15.9600 27.5400 14.1600 18.1500 17.32%
2014 15.7275 17.1400 21.5400 11.6500 15.4700 -9.00%
2013 11.2478 6.9600 17.3300 5.7200 17.0000 154.11%
2012 4.3827 3.1500 8.0000 2.7000 6.6900 119.34%
2011 6.4065 6.4000 13.1500 2.6400 3.0500 -51.65%
2010 8.1390 7.7000 12.5000 5.7000 6.3080 -18.08%
2009 9.7689 4.9000 24.7000 4.1500 7.7000 64.71%
2008 6.0865 8.3000 9.1000 3.4990 4.6750 -43.33%
2007 8.8034 9.0000 15.6000 5.7700 8.2500 -6.25%
2006 16.1199 21.3000 31.2000 8.5000 8.8000 -55.33%
2005 12.6981 23.0000 23.0000 8.2000 19.7000 -10.41%
2004 23.1546 30.3000 40.9000 10.1000 21.9900 -25.96%
2003 20.0217 4.8000 34.2000 4.1000 29.7000 561.47%
2002 17.7450 39.4000 39.4000 3.5000 4.4900 -88.25%
2001 45.0065 37.5000 89.9000 24.7000 38.2000 10.12%
2000 166.4676 110.0000 455.0000 26.8750 34.6880 -69.84%
1999 57.0461 67.5000 115.0000 33.7520 115.0000 70.37%
1998 77.4331 70.0000 155.0000 20.0000 67.5000 -6.90%
1997 100.8424 82.5000 155.0000 66.2480 72.5000 -9.38%
1996 101.0310 105.0000 157.5000 72.5000 80.0000 -21.95%
1995 83.9087 102.5000 120.0000 50.0000 102.5000 -2.38%
1994 253.8046 445.0000 460.0000 80.0000 105.0000 -76.14%
1993 319.4862 390.0000 445.0000 230.0000 440.0000 10.00%
1992 358.3858 710.0000 720.0000 210.0000 400.0000 -45.21%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $19.024B $0.364B
Insmed is a biopharmaceutical company engaged in the development and commercialization of ARIKAYCE, or liposomal amikacin for inhalation, for at least two identified orphan patient populations: patients with nontuberculous mycobacteria (NTM) lung infections and cystic fibrosis (CF) patients with Pseudomonas aeruginosa lung infections. Insmed is also focused on the development of INS1009, the company's inhaled treprostinil prodrug for the treatment of pulmonary arterial hypertension (PAH), a chronic, life-threatening disorder characterized by abnormally high blood pressure in the arteries between the heart and lungs.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $220.098B 16.43
Amgen (AMGN) United States $155.962B 13.97
Gilead Sciences (GILD) United States $134.344B 13.95
Vertex Pharmaceuticals (VRTX) United States $113.502B 0.00
Bristol Myers Squibb (BMY) United States $96.117B 6.43
GSK (GSK) United Kingdom $81.410B 9.74
CSL (CSLLY) Australia $75.711B 0.00
Regeneron Pharmaceuticals (REGN) United States $54.939B 13.34
Alnylam Pharmaceuticals (ALNY) United States $40.252B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $38.570B 0.00
Argenex SE (ARGX) Netherlands $33.016B 90.12
BioNTech SE (BNTX) Germany $25.234B 0.00
Royalty Pharma (RPRX) United States $19.431B 8.21
Biogen (BIIB) United States $18.545B 8.00
Genmab (GNMSF) Denmark $14.702B 15.03
Illumina (ILMN) United States $14.163B 26.87
Genmab (GMAB) Denmark $14.126B 15.85
Incyte (INCY) United States $13.320B 101.19
Swedish Orphan Biovitrum (BIOVF) Sweden $11.389B 29.08
Exelixis (EXEL) United States $11.278B 19.15
Ascendis Pharma (ASND) Denmark $10.570B 0.00
BioMarin Pharmaceutical (BMRN) United States $10.548B 17.13
QIAGEN (QGEN) Netherlands $10.348B 20.13
Exact Sciences (EXAS) United States $9.911B 0.00
Moderna (MRNA) United States $9.881B 0.00
Blueprint Medicines (BPMC) United States $8.281B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $7.911B 0.00
Bio-Techne Corp (TECH) United States $7.760B 28.95
Roivant Sciences (ROIV) United Kingdom $7.553B 0.00
Revolution Medicines (RVMD) United States $7.291B 0.00
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Repligen (RGEN) United States $6.799B 76.11
Halozyme Therapeutics (HALO) United States $6.544B 12.53
Jazz Pharmaceuticals (JAZZ) Ireland $6.478B 6.36
Legend Biotech (LEGN) United States $6.377B 0.00
Guardant Health (GH) United States $6.136B 0.00
Telix Pharmaceuticals (TLX) Australia $5.681B 0.00
TG Therapeutics (TGTX) United States $5.556B 145.83
Nuvalent (NUVL) United States $5.462B 0.00
Axsome Therapeutics (AXSM) United States $5.002B 0.00
Alkermes (ALKS) Ireland $4.909B 13.17
ADMA Biologics Inc (ADMA) United States $4.510B 33.73
Akero Therapeutics (AKRO) United States $4.416B 0.00
Vaxcyte (PCVX) United States $4.340B 0.00
Zai Lab (ZLAB) China $4.106B 0.00
Zealand Pharma (ZLDPF) Denmark $4.064B 0.00
PTC Therapeutics (PTCT) United States $4.030B 7.01
Rhythm Pharmaceuticals (RYTM) United States $3.943B 0.00
Cytokinetics (CYTK) United States $3.886B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.816B 33.53
Krystal Biotech (KRYS) United States $3.757B 28.96
CRISPR Therapeutics AG (CRSP) Switzerland $3.730B 0.00
Merus (MRUS) Netherlands $3.674B 0.00
Avidity Biosciences (RNA) United States $3.538B 0.00
SpringWorks Therapeutics (SWTX) United States $3.531B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.466B 0.00
Arcellx (ACLX) United States $3.465B 0.00
Protagonist Therapeutics (PTGX) United States $3.422B 73.61
Kymera Therapeutics (KYMR) United States $3.018B 0.00
Viking Therapeutics (VKTX) United States $2.968B 0.00
Scholar Rock Holding (SRRK) United States $2.958B 0.00
Alvotech (ALVO) Luxembourg $2.780B 15.90
Ascentage Pharma Group - (AAPG) China $2.756B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.753B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.739B 0.00
Metsera (MTSR) United States $2.666B 0.00
Immunovant (IMVT) United States $2.617B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.511B 0.00
ImmunityBio (IBRX) United States $2.507B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.432B 0.00
Apellis Pharmaceuticals (APLS) United States $2.232B 0.00
Ligand Pharmaceuticals (LGND) United States $2.171B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.141B 0.00
Sarepta Therapeutics (SRPT) United States $2.119B 0.00
Bavarian Nordic (BVNRY) Denmark $2.103B 11.11
Vericel (VCEL) United States $2.089B 1383.33
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.040B 0.00
Denali Therapeutics (DNLI) United States $2.035B 0.00
Twist Bioscience (TWST) United States $2.032B 0.00
Agios Pharmaceuticals (AGIO) United States $2.009B 0.00
CG Oncology (CGON) United States $2.000B 0.00
NovoCure (NVCR) Jersey $1.943B 0.00
IDEAYA Biosciences (IDYA) United States $1.920B 0.00
Apogee Therapeutics (APGE) United States $1.918B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.865B 12.39
Belite Bio (BLTE) United States $1.864B 0.00
Amicus Therapeutics (FOLD) United States $1.786B 193.33
Disc Medicine (IRON) United States $1.733B 0.00
Certara (CERT) United States $1.715B 32.03
Beam Therapeutics (BEAM) United States $1.676B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.656B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.626B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.581B 0.00
Adaptive Biotechnologies (ADPT) United States $1.540B 0.00
Edgewise Therapeutics (EWTX) United States $1.524B 0.00
GRAIL (GRAL) United States $1.513B 0.00
Mesoblast (MESO) Australia $1.504B 0.00
Biohaven (BHVN) United States $1.487B 0.00
89BIO (ETNB) United States $1.451B 0.00
Anbio Biotechnology (NNNN) Germany $1.432B 0.00
ANI Pharmaceuticals (ANIP) United States $1.372B 14.14
Janux Therapeutics (JANX) United States $1.356B 0.00
Vera Therapeutics (VERA) United States $1.349B 0.00
Celldex Therapeutics (CLDX) United States $1.332B 0.00
Travere Therapeutics (TVTX) United States $1.251B 0.00
CureVac (CVAC) Germany $1.234B 5.98
BGM Group (BGM) China $1.230B 0.00
Viridian Therapeutics (VRDN) United States $1.210B 0.00
Structure Therapeutics (GPCR) United States $1.202B 0.00
Dynavax Technologies (DVAX) United States $1.200B 71.36
Liquidia Technologies (LQDA) United States $1.162B 0.00
MannKind (MNKD) United States $1.140B 23.44
Pacira BioSciences (PCRX) United States $1.129B 10.74
Niagen Bioscience (NAGE) United States $1.093B 154.22
Novavax (NVAX) United States $1.051B 2.45
WAVE Life Sciences (WVE) Singapore $1.016B 0.00
Intellia Therapeutics (NTLA) United States $0.992B 0.00
CorMedix Inc (CRMD) United States $0.945B 63.36
AbCellera Biologics (ABCL) Canada $0.931B 0.00
Geron (GERN) United States $0.924B 0.00
Arcus Biosciences (RCUS) United States $0.921B 0.00
Spyre Therapeutics (SYRE) United States $0.915B 0.00
NeoGenomics (NEO) United States $0.900B 0.00
Mineralys Therapeutics (MLYS) United States $0.898B 0.00
Praxis Precision Medicines (PRAX) United States $0.885B 0.00
Nurix Therapeutics (NRIX) United States $0.868B 0.00
Cogent Biosciences (COGT) United States $0.868B 0.00
Pharvaris (PHVS) Netherlands $0.866B 0.00
MiMedx (MDXG) United States $0.864B 20.89
Oculis Holding AG (OCS) Switzerland $0.861B 0.00
ArriVent BioPharma (AVBP) United States $0.855B 0.00
Zymeworks (ZYME) United States $0.852B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.830B 0.00
LENZ Therapeutics (LENZ) United States $0.815B 0.00
UniQure (QURE) Netherlands $0.810B 0.00
Immunome (IMNM) United States $0.779B 0.00
Oric Pharmaceuticals (ORIC) United States $0.770B 0.00
Anavex Life Sciences (AVXL) United States $0.762B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.760B 0.00
Gyre Therapeutics (GYRE) United States $0.759B 202.25
Pharming Group (PHAR) Netherlands $0.758B 0.00
Pharming Group (PHGUF) Netherlands $0.748B 0.00
Immatics (IMTX) Germany $0.746B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.733B 0.00
Replimune (REPL) United States $0.733B 0.00
Trevi Therapeutics (TRVI) United States $0.718B 0.00
Vir Biotechnology (VIR) United States $0.705B 0.00
AnaptysBio (ANAB) United States $0.700B 0.00
Iovance Biotherapeutics (IOVA) United States $0.675B 0.00
Arbutus Biopharma (ABUS) United States $0.661B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.659B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Stoke Therapeutics (STOK) United States $0.637B 14.76
Sana Biotechnology (SANA) United States $0.634B 0.00
GH Research (GHRS) Ireland $0.624B 0.00
Sionna Therapeutics (SION) United States $0.611B 0.00
Urogen Pharma (URGN) United States $0.610B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.606B 0.00
Nuvation Bio (NUVB) United States $0.582B 0.00
Sage Therapeutics (SAGE) United States $0.571B 0.00
Dianthus Therapeutics (DNTH) United States $0.555B 0.00
Upstream Bio (UPB) United States $0.555B 0.00
Keros Therapeutics (KROS) United States $0.547B 0.00
Arvinas (ARVN) United States $0.546B 0.00
Maze Therapeutics (MAZE) United States $0.543B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.540B 0.00
Kura Oncology (KURA) United States $0.537B 0.00
Castle Biosciences (CSTL) United States $0.535B 36.35
Bicycle Therapeutics (BCYC) United Kingdom $0.529B 0.00
Bicara Therapeutics (BCAX) United States $0.527B 0.00
Opthea (OPT) Australia $0.525B 0.00
Tango Therapeutics (TNGX) United States $0.521B 0.00
Tyra Biosciences (TYRA) United States $0.509B 0.00
MeiraGTx Holdings (MGTX) United States $0.509B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.507B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.500B 0.00
Fortrea Holdings (FTRE) United States $0.494B 13.65
Cullinan Therapeutics (CGEM) United States $0.491B 0.00
Myriad Genetics (MYGN) United States $0.459B 0.00
ATyr Pharma (ATYR) United States $0.457B 0.00
Septerna (SEPN) United States $0.456B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.453B 0.00
Celcuity (CELC) United States $0.446B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.445B 0.00
REGENXBIO (RGNX) United States $0.434B 0.00
PureTech Health (PRTC) United States $0.426B 0.00
Precigen (PGEN) United States $0.419B 0.00
Kamada (KMDA) Israel $0.411B 24.62
Benitec Biopharma (BNTC) United States $0.405B 0.00
Zenas BioPharma (ZBIO) United States $0.405B 0.00
Cytek Biosciences (CTKB) United States $0.404B 0.00
Rapport Therapeutics (RAPP) United States $0.400B 0.00
Northwest Biotherapeutics (NWBO) United States $0.390B 0.00
Erasca (ERAS) United States $0.387B 0.00
Abivax SA (ABVX) France $0.384B 0.00
ITeos Therapeutics (ITOS) United States $0.384B 0.00
Tectonic Therapeutic (TECX) United States $0.383B 0.00
Checkpoint Therapeutics (CKPT) United States $0.371B 0.00
Vigil Neuroscience (VIGL) United States $0.368B 0.00
Eton Pharmaceuticals (ETON) United States $0.365B 0.00
Humacyte (HUMA) United States $0.361B 0.00
Solid Biosciences (SLDB) United States $0.357B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.356B 0.00
Rezolute (RZLT) United States $0.353B 0.00
Fulcrum Therapeutics (FULC) United States $0.347B 0.00
Absci (ABSI) United States $0.346B 0.00
Terns Pharmaceuticals (TERN) United States $0.341B 0.00
Emergent Biosolutions (EBS) United States $0.338B 0.00
MBX Biosciences (MBX) United States $0.338B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.333B 0.00
Inventiva S.A (IVA) France $0.329B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.323B 0.00
Astria Therapeutics (ATXS) United States $0.322B 0.00
Ocugen (OCGN) United States $0.318B 0.00
Aura Biosciences (AURA) United States $0.311B 0.00
Abeona Therapeutics (ABEO) United States $0.307B 0.00
Prothena (PRTA) Ireland $0.307B 0.00
Compass Therapeutics (CMPX) United States $0.303B 0.00
Verastem (VSTM) United States $0.292B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.290B 0.00
Alpha Teknova (TKNO) United States $0.288B 0.00
XOMA Royalty (XOMA) United States $0.286B 0.00
Allogene Therapeutics (ALLO) United States $0.284B 0.00
Gossamer Bio (GOSS) United States $0.282B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.281B 57.12
Amarin (AMRN) Ireland $0.278B 0.00
Cidara Therapeutics (CDTX) United States $0.277B 0.00
Atea Pharmaceuticals (AVIR) United States $0.275B 0.00
Olema Pharmaceuticals (OLMA) United States $0.274B 0.00
Entrada Therapeutics (TRDA) United States $0.274B 8.90
Corvus Pharmaceuticals (CRVS) United States $0.269B 0.00
Foghorn Therapeutics (FHTX) United States $0.267B 0.00
2seventy Bio (TSVT) United States $0.266B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.265B 0.00
Neurogene (NGNE) United States $0.263B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.260B 0.00
DBV Technologies S.A (DBVT) France $0.259B 0.00
Inozyme Pharma (INZY) United States $0.257B 0.00
Annexon (ANNX) United States $0.257B 0.00
Cartesian Therapeutics (RNAC) United States $0.254B 0.00
Lifecore Biomedical (LFCR) United States $0.252B 0.00
Candel Therapeutics (CADL) United States $0.248B 0.00
Cardiff Oncology (CRDF) United States $0.246B 0.00
Third Harmonic Bio (THRD) United States $0.245B 0.00
Aardvark Therapeutics (AARD) United States $0.245B 0.00
Prima BioMed (IMMP) Australia $0.242B 0.00
BioStem Technologies (BSEM) $0.236B 9.63
Palvella Therapeutics (PVLA) United States $0.235B 0.00
Tvardi Therapeutics (TVRD) United States $0.235B 0.00
ACELYRIN, INC (SLRN) United States $0.229B 0.00
MaxCyte (MXCT) United States $0.229B 0.00
Semper Paratus Acquisition (TVGN) United States $0.224B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.217B 0.00
Adocia (ADOCY) France $0.213B 0.00
Adherex Technologies (FENC) United States $0.213B 0.00
Prime Medicine (PRME) United States $0.212B 0.00
Inhibrx Biosciences (INBX) United States $0.211B 0.13
Sagimet Biosciences (SGMT) United States $0.211B 0.00
ScPharmaceuticals (SCPH) United States $0.211B 0.00
Design Therapeutics (DSGN) United States $0.209B 0.00
Monopar Therapeutics (MNPR) United States $0.209B 0.00
GENFIT S.A (GNFT) France $0.204B 0.00
I-Mab (IMAB) United States $0.202B 0.00
CARGO Therapeutics (CRGX) United States $0.202B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.199B 0.00
Bright Minds Biosciences (DRUG) United States $0.195B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.193B 0.00
AC Immune (ACIU) Switzerland $0.193B 0.00
CytomX Therapeutics (CTMX) United States $0.192B 4.96
Kodiak Sciences (KOD) United States $0.187B 0.00
Codexis (CDXS) United States $0.184B 0.00
Instil Bio (TIL) United States $0.183B 0.00
Editas Medicine (EDIT) United States $0.179B 0.00
Innate Pharma S.A (IPHA) France $0.177B 0.00
Voyager Therapeutics (VYGR) United States $0.173B 0.00
Puma Biotechnology (PBYI) United States $0.170B 4.45
Nuvectis Pharma (NVCT) United States $0.169B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.168B 0.00
EnGene Holdings (ENGN) Canada $0.166B 0.00
Spero Therapeutics (SPRO) United States $0.162B 0.00
Anika Therapeutics (ANIK) United States $0.158B 0.00
INmune Bio (INMB) United States $0.158B 0.00
Ventyx Biosciences (VTYX) United States $0.157B 0.00
BioAge Labs (BIOA) United States $0.156B 0.00
Galena Biopharma (SLS) United States $0.156B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.154B 0.00
DiaMedica Therapeutics (DMAC) United States $0.153B 0.00
Actuate Therapeutics (ACTU) United States $0.152B 0.00
Alector (ALEC) United States $0.152B 0.00
Molecular Partners AG (MOLN) Switzerland $0.152B 0.00
Compugen (CGEN) Israel $0.147B 0.00
Alpha Cognition (ACOG) Canada $0.146B 0.00
Alumis (ALMS) United States $0.142B 0.00
Fate Therapeutics (FATE) United States $0.138B 0.00
BeyondSpring (BYSI) United States $0.137B 0.00
Black Diamond Therapeutics (BDTX) United States $0.132B 38.67
Agenus (AGEN) United States $0.131B 0.00
Rapt Therapeutics (RAPT) United States $0.130B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.129B 0.00
Nkarta (NKTX) United States $0.128B 0.00
Neumora Therapeutics (NMRA) United States $0.128B 0.00
Kyverna Therapeutics (KYTX) United States $0.128B 0.00
Elicio Therapeutics (ELTX) United States $0.127B 0.00
Greenwich LifeSciences (GLSI) United States $0.121B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.119B 0.00
Seer (SEER) United States $0.115B 0.00
BioHarvest Sciences (BHST) Canada $0.114B 0.00
Genelux (GNLX) United States $0.114B 0.00
Theratechnologies (THTX) Canada $0.113B 0.00
Sangamo Therapeutics (SGMO) United States $0.113B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.112B 0.00
Biomea Fusion (BMEA) United States $0.109B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.108B 0.00
Caribou Biosciences (CRBU) United States $0.108B 0.00
TuHURA Biosciences (HURA) United States $0.107B 0.00
23andMe Holding (MEHCQ) United States $0.107B 0.00
C4 Therapeutics (CCCC) United States $0.106B 0.00
EXoZymes (EXOZ) United States $0.104B 0.00
Citius Oncology (CTOR) United States $0.104B 0.00
Contineum Therapeutics (CTNM) United States $0.102B 0.00
Entera Bio (ENTX) Israel $0.095B 0.00
Whitehawk Therapeutics (WHWK) United States $0.095B 0.00
Cabaletta Bio (CABA) United States $0.095B 0.00
Tenaya Therapeutics (TNYA) United States $0.093B 0.00
HilleVax (HLVX) United States $0.093B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.092B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.092B 0.00
Adagene (ADAG) China $0.090B 0.00
Coya Therapeutics (COYA) United States $0.089B 0.00
Nautilus Biotechnology (NAUT) United States $0.088B 0.00
Coherus Oncology (CHRS) United States $0.088B 0.00
Invivyd (IVVD) United States $0.087B 0.00
TScan Therapeutics (TCRX) United States $0.087B 0.00
IO Biotech (IOBT) Denmark $0.087B 0.00
Forte Biosciences (FBRX) United States $0.082B 0.00
Jasper Therapeutics (JSPR) United States $0.081B 0.00
Climb Bio (CLYM) United States $0.081B 0.00
Pliant Therapeutics (PLRX) United States $0.080B 0.00
XBiotech (XBIT) United States $0.080B 0.00
Zura Bio (ZURA) United States $0.078B 0.00
Cellectis S.A (CLLS) France $0.076B 0.00
OKYO Pharma (OKYO) $0.075B 0.00
PDS Biotechnology (PDSB) United States $0.074B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.074B 0.00
Immunic (IMUX) United States $0.074B 0.00
Elutia (ELUT) United States $0.073B 0.00
Senti Biosciences (SNTI) United States $0.073B 0.00
IGM Biosciences (IGMS) United States $0.071B 0.00
Inovio Pharmaceuticals (INO) United States $0.070B 0.00
Quantum Biopharma (QNTM) Canada $0.070B 0.00
VistaGen Therapeutics (VTGN) United States $0.069B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.068B 0.00
Sutro Biopharma (STRO) United States $0.067B 0.00
Ikena Oncology (IKNA) United States $0.066B 0.00
Immuneering (IMRX) United States $0.065B 0.00
Skye Bioscience (SKYE) United States $0.064B 0.00
Seres Therapeutics (MCRB) United States $0.064B 0.00
Immix Biopharma (IMMX) United States $0.064B 0.00
Oncolytics Biotech (ONCY) Canada $0.063B 0.00
Akoya Biosciences (AKYA) United States $0.062B 0.00
Renovaro (RENB) United States $0.062B 0.00
Quince Therapeutics (QNCX) United States $0.062B 0.00
MediciNova (MNOV) United States $0.062B 0.00
CervoMed (CRVO) United States $0.061B 0.00
Clearside Biomedical (CLSD) United States $0.061B 0.00
Repare Therapeutics (RPTX) Canada $0.061B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.061B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.060B 0.00
Alto Neuroscience (ANRO) United States $0.060B 0.00
Connect Biopharma Holdings (CNTB) United States $0.060B 0.00
Genenta Science S.p.A (GNTA) Italy $0.060B 0.00
TELA Bio (TELA) United States $0.059B 0.00
Oncobiologics (OTLK) United States $0.057B 0.00
Adicet Bio (ACET) United States $0.056B 0.00
Adlai Nortye (ANL) Cayman Islands $0.055B 0.00
Opus Genetics (IRD) United States $0.055B 0.00
Precision BioSciences (DTIL) United States $0.054B 0.00
Werewolf Therapeutics (HOWL) United States $0.054B 0.00
ZIVO Bioscience (ZIVO) United States $0.054B 0.00
Fortress Biotech (FBIO) United States $0.054B 0.00
Kronos Bio (KRON) United States $0.054B 0.00
Exicure (XCUR) United States $0.053B 0.00
InflaRx (IFRX) Germany $0.052B 0.00
Annovis Bio (ANVS) United States $0.051B 0.00
VTv Therapeutics (VTVT) United States $0.050B 0.00
RenovoRx (RNXT) United States $0.049B 0.00
Applied Therapeutics (APLT) United States $0.049B 0.00
Bluebird Bio (BLUE) United States $0.049B 0.00
Adverum Biotechnologies (ADVM) United States $0.048B 0.00
Kalaris Therapeutics (KLRS) United States $0.048B 0.00
Shattuck Labs (STTK) United States $0.047B 0.00
Atara Biotherapeutics (ATRA) United States $0.047B 0.00
PepGen (PEPG) United States $0.046B 0.00
Aligos Therapeutics (ALGS) United States $0.046B 0.00
Mersana Therapeutics (MRSN) United States $0.044B 0.00
Artiva Biotherapeutics (ARTV) United States $0.044B 0.00
Cue Biopharma (CUE) United States $0.044B 0.00
Celularity (CELU) United States $0.042B 0.00
Radiopharm Theranostics - (RADX) Australia $0.041B 0.00
Rein Therapeutics (RNTX) United States $0.040B 0.00
Alterity Therapeutics - (ATHE) Australia $0.038B 0.00
Clene (CLNN) United States $0.038B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.038B 0.00
AN2 Therapeutics (ANTX) United States $0.036B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.036B 0.00
Medicus Pharma (MDCX) United States $0.035B 0.00
Xilio Therapeutics (XLO) United States $0.034B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.034B 0.00
Lantern Pharma (LTRN) United States $0.034B 0.00
ABVC BioPharma (ABVC) United States $0.034B 0.00
Pluri (PLUR) Israel $0.033B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.033B 0.00
OnKure Therapeutics (OKUR) United States $0.033B 0.00
Estrella Immunopharma (ESLA) United States $0.033B 0.00
Scilex Holding (SCLX) United States $0.032B 0.00
Kezar Life Sciences (KZR) United States $0.030B 0.00
MiNK Therapeutics (INKT) United States $0.030B 0.00
Allakos (ALLK) United States $0.030B 0.00
Rani Therapeutics Holdings (RANI) United States $0.030B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.029B 0.00
Grace Therapeutics (GRCE) Canada $0.029B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.029B 0.00
FibroBiologics (FBLG) United States $0.029B 0.00
CAMP4 Therapeutics (CAMP) United States $0.028B 0.00
Dyadic (DYAI) United States $0.028B 0.00
KALA BIO (KALA) United States $0.027B 0.00
ALX Oncology Holdings (ALXO) United States $0.026B 0.00
Cadrenal Therapeutics (CVKD) United States $0.026B 0.00
Vor Biopharma (VOR) $0.026B 0.00
Generation Bio (GBIO) United States $0.026B 0.00
Dare Bioscience (DARE) United States $0.026B 0.00
Curis (CRIS) United States $0.025B 0.00
Beyond Air (XAIR) United States $0.025B 0.00
Passage Bio (PASG) United States $0.024B 0.00
CalciMedica (CALC) United States $0.024B 0.00
Tenax Therapeutics (TENX) United States $0.024B 0.00
Boundless Bio (BOLD) United States $0.024B 0.00
Femasys (FEMY) United States $0.023B 0.00
BioAtla (BCAB) United States $0.023B 0.00
Chemomab Therapeutics (CMMB) Israel $0.023B 0.00
Elevation Oncology (ELEV) United States $0.023B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.022B 0.00
Ovid Therapeutics (OVID) United States $0.022B 0.00
Lisata Therapeutics (LSTA) United States $0.021B 0.00
Eyenovia (EYEN) United States $0.020B 0.00
Imunon (IMNN) United States $0.020B 0.00
Q32 Bio (QTTB) United States $0.020B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.019B 0.00
Cingulate (CING) United States $0.019B 0.00
Longeveron (LGVN) United States $0.018B 0.00
Advanced Biomed (ADVB) United States $0.018B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.018B 0.00
Lexaria Bioscience (LEXX) Canada $0.018B 0.00
Gelteq (GELS) Australia $0.017B 0.00
Cognition Therapeutics (CGTX) United States $0.017B 0.00
Hoth Therapeutics (HOTH) United States $0.017B 0.00
SAB Biotherapeutics (SABS) United States $0.017B 0.00
HOOKIPA Pharma (HOOK) United States $0.016B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.016B 0.00
Promis Neurosciences (PMN) Canada $0.016B 0.00
X4 Pharmaceuticals (XFOR) United States $0.016B 0.00
Leap Therapeutics (LPTX) United States $0.016B 0.00
Synlogic (SYBX) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Rallybio (RLYB) United States $0.014B 0.00
GeoVax Labs (GOVX) United States $0.014B 0.00
MetaVia (MTVA) United States $0.014B 0.00
IBio (IBIO) United States $0.013B 0.00
Abpro Holdings (ABP) United States $0.013B 0.00
UNITY Biotechnology (UBX) United States $0.013B 0.00
Biorestorative Therapies (BRTX) United States $0.013B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.013B 0.00
NextCure (NXTC) United States $0.013B 0.00
Athira Pharma (ATHA) United States $0.013B 0.00
Allarity Therapeutics (ALLR) United States $0.012B 0.00
Aytu BioPharma (AYTU) United States $0.012B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.012B 0.00
Equillium (EQ) United States $0.012B 0.00
BRIACELL THERAP (BCTX) Canada $0.012B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Bionano Genomics (BNGO) United States $0.011B 0.00
BioCardia (BCDA) United States $0.011B 0.00
Bolt Biotherapeutics (BOLT) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Cyclerion Therapeutics (CYCN) United States $0.010B 0.00
BioXcel Therapeutics (BTAI) United States $0.010B 0.00
Aprea Therapeutics (APRE) United States $0.010B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.009B 0.00
Moleculin Biotech (MBRX) United States $0.009B 0.00
Novogen (KZIA) Australia $0.009B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
LakeShore Biopharma (LSB) China $0.009B 0.00
Turnstone Biologics (TSBX) United States $0.009B 0.00
Evogene (EVGN) Israel $0.008B 0.00
GENPREX (GNPX) United States $0.008B 0.00
Sensei Biotherapeutics (SNSE) United States $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.008B 0.00
BioAffinity Technologies (BIAF) United States $0.008B 0.00
HCW Biologics (HCWB) United States $0.008B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Apollomics (APLM) United States $0.007B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.007B 0.00
Jade Biosciences (JBIO) United States $0.007B 0.00
Arcadia Biosciences (RKDA) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.006B 0.00
IN8bio (INAB) United States $0.006B 0.00
Portage Biotech (PRTG) $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
Pasithea Therapeutics (KTTA) United States $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Avalon GloboCare (ALBT) United States $0.006B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
Mainz Biomed (MYNZ) Germany $0.005B 0.00
180 Life Sciences (ATNF) United States $0.005B 0.00
Intensity Therapeutics (INTS) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.005B 0.00
Mustang Bio (MBIO) United States $0.004B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
VivoSim Labs (VIVS) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.003B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.003B 0.00
Affimed (AFMD) Germany $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Adial Pharmaceuticals (ADIL) United States $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.001B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
NuCana (NCNA) United Kingdom $0.001B 0.00
Capstone Holding� (CAPS) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00